Reporting laws
13 laws in 12 states. A law of this kind requires covered entities, or others, to report 340B figures to the state, or a state office to publish them.
- CaliforniaProtect Patients Now Act of 20242024An entity that meets the act's test of a 'prescription drug price manipulator' keeps its tax-exempt status and its pharmacy, health plan or clinic licences only if, in the prior year, it spent at least 98 percent of its California net revenue from the 340B program on direct patient care. It sends a yearly accounting to state agencies.
- ColoradoColorado 340B Contract Pharmacy Protection Act2025Manufacturers, their logistics providers and repackagers may not deny, restrict or limit 340B drugs reaching a covered entity, its contract pharmacy or another authorized location, and may not require claims or other data as a condition. Hospital covered entities report their 340B savings, costs and charity care each year, and may not spend savings on a listed set of items such as lobbying, advertising and board travel.
- HawaiiHRS chapter 481N2025A manufacturer may not deny, restrict or prohibit delivery of 340B drugs to a pharmacy under contract with a covered entity; it may ask for claims data, up to three years back, to check for diversion and duplicate discounts. From July 1, 2026 each covered entity reports contract pharmacy figures to the hospital trade association, which posts a combined public report from October 1, 2027.
- IdahoIdaho Code 41-3512025Before April 1 each year a 340B covered entity reports to the Department of Health and Welfare, the State Controller and the Attorney General: what it paid for 340B drugs, what it was paid for them, what it paid contract pharmacies, claim counts and how it uses the savings, split by commercial, Medicaid and Medicare. The Controller publishes a combined report each November.
- IllinoisPatient Access to Pharmacy Protection Act2026No person, a drug manufacturer included, may deny, restrict or place conditions on 340B drugs reaching a covered entity or its contract pharmacy, limit the number or place of contract pharmacies, or demand pricing or claims data. Covered entities file a yearly 340B report with the General Assembly and keep a policy against duplicate discounts; the state Medicaid agency reports once on 340B units and savings.
- Illinois340B Transparency, Reporting, and Accountability Act2026The Department of Insurance studies how 340B covered entities and drug manufacturers in Illinois take part in the program and reports to the General Assembly and the Governor by July 1, 2028. Covered entities and manufacturers answer its requests on acquisition cost, payments received, contract pharmacies and the use of savings.
- IndianaIC 16-40-62025Before April 1 each year a 340B covered entity with an Indiana service address reports to the state Department of Health: its 340B acquisition costs, payments received, payments to contract pharmacies, how it uses 340B savings, charity care included, and its financial assistance policy. The department publishes a combined report each year.
- Maine22 M.R.S. 17282023Each Maine hospital in the 340B program files a yearly report with the Maine Health Data Organization on how it uses 340B savings for its community, its estimated savings set against its total drug spending, and how it oversees the program. The organization posts the reports and a summary.
- MinnesotaMinn. Stat. 62J.4612024Each 340B covered entity with a Minnesota address keeps a registration with the Commissioner of Health and reports by April 1 each year what it paid for 340B drugs, what it was paid for them by payer type, units dispensed, and what it paid contract pharmacies and program managers. The commissioner reports combined results to the legislature each November 15.
- OhioR.C. 3701.882025Each 340B covered entity sends the Ohio Department of Health a yearly report: what it paid for 340B drugs, what it was paid for them by payer type, what it paid contract pharmacies and others, how many contract pharmacies it uses, and an accounting of what it spent from 340B proceeds. The department posts the reports on its website.
- Rhode IslandDefending Affordable Prescription Drug Costs Act2025Insurers, pharmacy benefit managers and other payers may not pay a 340B covered entity or contract pharmacy less, add fees or conditions, limit network participation or require a 340B marker on a claim. A manufacturer may not interfere with a 340B drug reaching a contract pharmacy. By April 1 each year a covered entity reports its 340B costs, payments, vendors and claims, and how it uses the savings.
- Vermont18 V.S.A. 4681 to 4685; 18 V.S.A. 94062025A manufacturer or its agent may not deny, restrict or interfere with a 340B drug reaching a covered entity's contract pharmacy, require claims or utilization data as a condition, or interfere with a contract pharmacy dispensing to eligible patients. Each hospital in the 340B program reports its 340B figures to the Green Mountain Care Board every January 31.
- WashingtonTitle 69 RCW (new chapter); chapter 43.71C RCW2026A manufacturer, or a third party acting for one, may not deny, restrict or prohibit a 340B drug reaching a covered entity, a contract pharmacy or an authorized location, and may not require data as a condition. Federally qualified health centers and certain hospitals report their 340B figures, the use of savings included, to the Health Care Authority by April 1 each year; manufacturers report 340B units and discounts.